Chronic Kidney Disease (CKD): Screening
Release Date: August 2012
Summary of Recommendation and Evidence
The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for chronic kidney disease (CKD) in asymptomatic adults.
|The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.|
Common tests considered for CKD screening include creatinine-derived estimates of glomerular filtration rate (GFR) and urine testing for albumin. Testing for and monitoring CKD for the purposes of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.
Go to the Clinical Considerations section for suggestions for practice regarding the I statement.
Internet Citation: Final Update Summary: Chronic Kidney Disease (CKD): Screening. U.S. Preventive Services Task Force. September 2016.